Better Data for Better Health
Login
Get Started

Geneyx In The News

  • RECENT PRESS

Discover How Geneyx Is Making Headlines

  • October 24, 2025

Geneyx Genomex and Omics Discoveries announced a partnership

Oct. 30, 2025 Geneyx a pioneering global company for an AI Multi-Omics analysis system, and Ocean Genomics, a leader in...
read more
  • September 19, 2024

Geneyx Joins Google’s AI First Accelerator: Boosting Europe’s innovator scene

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector....
read more
  • May 15, 2024

Geneyx Among the World’s Best Digital Health Companies in 2024

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector....
read more
  • March 13, 2024

Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a...
read more
  • November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partner Geneyx to PacBio Compatible

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers....
read more
  • July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx and Ocean Genomics develop a multiomic software method, combining DNA and RNA....
read more
  • July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

Geneyx and Ocean Genomics will develop a multiomic software method, combining DNA and RNA....
read more
  • June 21, 2023

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

This month's announcement that Oxford Nanopore Technologies would integrate its Epi2Me cloud-based analysis platform with Geneyx's software to automate analysis...
read more
  • June 9, 2023

Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing

The new platform is designed to enable the end-to-end analysis and clinical reporting of nanopore sequencing, empowering clinical labs, researchers...
read more
  • June 9, 2023

Oxford Nanopore Technologies and Geneyx announce the first scalable software solution to advance the future clinical use of nanopore sequencing

England--Oxford Nanopore Technologies. The new platform is designed to enable the end-to-end analysis and clinical reporting of nanopore sequencing, empowering...
read more
  • May 28, 2023

Geneyx Together with Digi7 Introduces Its AI-based Solution to Mediclinic Hospitals in UAE

UAE--Mediclinic. Digi7 launches Geneyx AI-based solution to analyse next-generation sequencing data at Mediclinic hospitals in Abu Dhabi, UAE Dubai, May...
read more
  • November 9, 2021

Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based...
read more
  • November 10, 2021

Geneyx Genomex Closes $6.5M Seed Financing Round

NEW YORK – Geneyx Genomex said Tuesday that it has closed a seed financing round worth approximately $6.5 million. Capri...
read more
  • October 10, 2020

Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm...
read more
  • April 8, 2020

Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors

NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm...
read more
+

Selected Videos

Schedule Demo

Contact us to set a live demo


Contact Us

Whether you have general questions about our solutions or would like to schedule a demo or to suggest collaboration – our team is on hand for you.